TLR2 and type 2 diabetes nephropathy: The said monoterpene reduced AGEs-induced TLR2/4 activation and inflammatory responses, indicating that it prevents macrophage activation by inhibiting TLR2/4 signaling expression in type 2 diabetic nephropathy [94].